Navigation Links
Psoriasis Increases Cancer Risk

People who suffer from the skin disease psoriasis are at an increased risk for cancer, according to new research. Specifically, study authors found patients with psoriasis had a nearly three-fold increased rate of lymphoma.// Psoriasis is a common skin disease that affects about 1 percent to 2 percent of the population. Patients with psoriasis have patches of thickened, red and scaly skin, usually on the torso or arms that can be painful and disfiguring. Lymphoma is a group of cancers that affect the lymph tissues found mainly in the lymph nodes and spleen. Previous research has found an association between psoriasis and lymphoma. Doctors from the University of Pennsylvania studied whether the rate of lymphoma in patients with a history of psoriasis is different from the rate of lymphoma in patients without psoriasis. Included in the study was a random sample of patients 65 years or older who were registered with a general practitioner. The research included 2,718 patients with psoriasis and 105,203 patients without psoriasis. Researchers kept track of who was diagnosed with lymphoma during a median follow up of 46 months. During the study period, researchers identified 276 lymphomas. Researchers say the patients with psoriasis were nearly three times more likely to be diagnosed with lymphoma than healthy participants. Furthermore, patients 65 years or older who had psoriasis developed an additional 122 lymphomas per 100,000 patients annually. After reviewing records, researchers found all the patients with psoriasis who had lymphoma were treated with medications consistent with psoriasis treatment. While researchers conclude there is an association between psoriasis and lymphoma, they feel additional research needs to be done to determine if this association is related to psoriasis severity, psoriasis treatment or an interaction between these risk factors.
'"/>




Page: 1

Related medicine news :

1. New and unique treatment for Psoriasis patients
2. Comparing Psoriasis Treatments
3. Help for Psoriasis
4. Managing Patients With Psoriasis
5. Effective Treatment Option For Psoriasis
6. Smoking Aggravates Psoriasis
7. Remicade Emerges as a Treatment for Patients Suffering From Psoriasis Disorder
8. Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis
9. Psoriasis raises risk for heart attack
10. Psoriasis Associated With Increased Risk For Heart Attack
11. Remicade Therapy Effective in Treating Severe Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... May 26, 2016 , ... ... the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm ... Dr. Maisel, founder of Retina Group of New York , is a ...
(Date:5/26/2016)... Los Angeles, CA (PRWEB) , ... May 26, 2016 , ... In an effort to ... Snapchat videos available to both Snapchat users and those who do not use the app. ... available on his new page, Dr. Mohebi Live . , Dr. Mohebi says, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life Science Logistics ... organization has earned its ISO 13485 certification, indicating the company’s quality control system ... and policies associated with ISO quality standard 13485. , BSI Group America, ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Lung Institute ... a six-week smoking cessation class starting June 6 at their clinic in downtown Tampa. ... . , Additionally, the Lung Institute has created a free downloadable 4 Week ...
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps at East ... practices, arts & crafts, discussions, and games all geared towards enhancing your child’s ... combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global yoga training. ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... May 24, 2016   ... beide primären Endpunkte und demonstriert Ebenbürtigkeit ... ‚ausgezeichneter plus guter , ... ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... neue positive Daten von der MORA-Studie der Phase ...
Breaking Medicine Technology: